Understanding The
LYME disease, classification and CODES. /
La enfermedad de LYME, clasificacion y
CODIGOS.
DATA-MEDICOS
DERMAGIC/EXPRESS 19-(207)
16 Diciembre 2.017 16 December 2.017
EDITORIAL ENGLISH
=================
Hello friends of the network DERMAGIC brings you today another
interesting topic about the very well known ERYTHEMA MIGRANS
or LYME DISEASE, transmitted by the bite of a
TICK, of the IXODES genus being the causal agent
an
ESPIROCHETE, well known as
BORRELIA BURDORGFERI, described for the first time
by WILLY BURGDORFER in the year 1.981, and previously
known as LYME ARTHRITIS. Today I bring you
THE CODES OF LYME'S DISEASE.
Currently worldwide LYME DISEASE has become a major public
health problem, due to the annual increase in cases, which
in the United States amounts to about
380,000, new cases annually,
2 times more than
breast cancer
and 6 times more than
AIDS, and beyond this, the lack of modernization of
the DISEASE CODES at the SOFTWARE or DIGITAL level,
them do not appear
currently and they need
to be recognized
so that patients to be and treated in time.
The events that I present below
they are
highly related to this lack of "CODIFICATION"
of the
LYME DISEASE
and its different ways of manifesting itself clinically:
1.) DIFFICULTY TO MAKE THE DIAGNOSIS:
===========================================================================
It is well known that some TEST, to diagnose the disease, result
in "NEGATIVE" due to the ability of the causative agent, the
spirochaete
BORRELIA
to "hide (BIOFILM) before the diagnostic
tests." Many patients with symptoms of different diseases such
as
MENINGITIS , ARTHRITIS, and
RECURRENT FEVER, in late stages it is discovered that
they are
LYME "POSITIVE" after having multiple tests for the
diagnosis,
losing a VALUABLE TIME to initiate an adequate
treatment, and the worse thing is that the chronic development
of these symptoms, impar the quality of life of patients who are
unattended because they do not have a SPECIFIC DIAGNOSIS.
2.) RESISTANCE TO CONVENTIONAL TREATMENT:
==============================================================================
Another aspect to consider is that
BORRELIA and its species over time have developed a
"GREAT RESISTANCE" to conventional therapy with the
usual antibiotic treatments: MINOCYCLINE, DOXICYCLINE,
AMOXICILLIN, CEFUROXIME, and many OTHERS, leading patients
to the despair at the occurrence of the codification of the
symptoms.
LYME DISEASE has
FOUR STAGES CLASSICALLY known:
INITIAL (I), SECONDARY (II), LATE (III) AND CHRONIC (IV).
3.) THE LACK OF MODERNIZATION OF THE CODES FOR THE LYME DISEASE:
==============================================================================
In this modern and GLOBALIZED world, digitalization and
information technology have become essential elements and
everything or almost
everything
HAS A CODE, even DISEASES at the software
level, and in the case of
LYME DISEASE these must be
UPDATED, and this is done based on the EVIDENCE
REPORTS, STUDIES AND PUBLICATIONS of the different
manifestations of the disease.
Then you will be asking why the
LYME DISEASE needs
the update of its CODES? If you enter in the World
Health Organization (WHO) and look for LYME DISEASE, you will
only find TWO (2) mentions in the subject
ZOONOSES, transmission by TICKS:
LYME DISEASE and
RECURRENT FEVER (BORRELIOSIS), and the latest
relevant reports in terms of studies of the disease by WHO date
from the years 1,993 and 1,995:
1.) WHO Workshop on Diagnosis and Surveillance of Lyme
Borreliosis. Warsaw, Poland, 20-22 June 1995, Ref.: WHO / CDS /
VPH / 95.141:
The countries involved were:
Austria, Bulgaria, Czech Republic, Denmark, Yugoslavia, France,
Hungary, Ireland, Japan,
Holland, Poland, Russia, Sweden, Switzerland, United
Kingdom
and the United States.
2.) Report of a WHO Workshop on Lyme Borreliosis. Piestany,
Slovak Republic, 6 October 1993, Ref: WHO / CDS / VPH / 93.132:
The countries involved:
Germany, Slovakia
and the United States. If you read those
reports you will notice that they are
TOTALLY OUT OF DATE regarding the REALITY of LYME
DISEASE today.
And I will always give you the answer.
I will place here more than
270 BIBLIOGRAPHY REFERENCES classified based
on the different manifestations of
LYME DISEASE or
LYME BORRELIOSIS that are sufficient to RECOGNIZE that
beyond
"LYME DISEASE" AND
"RECURRENT FEVER (BORRELIOSIS) there are other
manifestations of the BORRELIOSIS that should be
CODIFIED, DIGITALIZED, to give a
total coverage to the DISEASE and search of its
clinical manifestations.
This
"ABSENCE" of
CODES causes that many patients carrying LYME
are not treated ADEQUATELY, because they DO NOT
"APPEAR IN THE SYSTEM" with their respective
consequences.
Here I ask the INNOCENT question, what happens is
"UNKNOWN" or
"INTENTIONED"? because to recognize all these IMPLIED
CODES means
more public spending by the State and the
insurance companies.
1.) CONGENITAL LYME DISEASE:
Potential infection of the fetus with possibility of death:
- LYME BORRELIOSIS IN PREGNANT WOMEN.
- ERLICHIOSIS AND BORRELIOSIS IN PREGNANT WOMEN.
- THE INFECTIOUS ORIGINS OF STILLBIRTH.
- INTRAUTERINE TRANSMISSION OF BORRELIA BURGDORFERI IN DOGS.
2.) LYME DISEASE: PRIMARY INFECTION:
- NEWBORN DEAD WOMAN PREGNANT WITH LYME DISEASE.
- LYME BBORRELIOSIS, IMPLICATION FOR THE FETUS.
- FETAL BORRELIOSIS, TEXEMIA OF PREGNANCY AND FETAL DEATH.
- ERITEMA MIGRANS IN PREGNANCY.
- FETAL MATERNAL TRANSMISSION OF LYME DISEASE.
- BORRELIA BURDOGFERI IN NEWBORN.
A.) PRIMARY INFECTION AND ERYTHEMA MIGRANS.
- PRIMARY AND SECONDARY ERYTHEMA MIGRANS.
B.) PRIMARY SERONEGATIVE INFECTION.
- NEGATIVE ANTIGENS AGAINST BORRELIA BURGDORFERI IN CEREBOSPINAL
FLUID IN NEUROLOGIC LYME DISEASE.
- SERONEGATIVE LYME DISEASE.
- SERONEGATIVE CHRONIC RELAPSING NEUROBORRELIOSIS.
3.) LYME DISEASE, PERSISTENT INFECTION IN SECONDARY AND LATE
STAGE
- PERSISTENT INFECTION WITH ANTIBIOTICS DOXYCYLINE AND
AMOXICILLIN.
- ISOLATION OF BORRELIA BURGDORFERI FROM OCULAR IRIS.
- SURVIVAL OF BORRELIA BURGDORFERI AFTER THERAPY WITH ANTIBIOTIC.
4.) LYME DISEASE, PERSISTENT INFECTION IN SECONDARY AND LATE
STAGE:
A.) CUTANEOUS MANIFESTATIONS:
- BORRELIAL LYMPHOCYTOMA (BL).
- ACRODERMATITIS ATROPHICANS.
- ANNULARE GRANULOMA.
- MORPHEA.
- LOCALIZED SCLERODERMA.
- LICHEN SCLEROSUS AND ATROPHICUS.
B.) OTHER CUTANEOUS MANIFESTATIONS:
- BENIGN LYMPHOCYTIC INFILTRATION OF JESSNER KANOF.
- INFANTILE ACRODERMATITIS OF GIANOTTI-CROSTI.
- ATYPICAL ERYTHEMA MULTIFORME.
- URTICARIAL VASCULITIS.
5.) LYME DISEASE OF SKIN AND MUCOUS MEMBRANES:
- ASSOCIATION OF LYME DISEASE WITH MORGELLONS DISEASE.
- DIFUSSE ALOPECIA.
- SCLERODERMA IN CUP DE SABRE.
- PSEUDOPELADE OF BROCQ.
6.) LYME DISEASE AND OTHER LESIONS:
- ANETODERMA.
- PRIMARY AND SECONDARY ERYTHEMA MIGRANS IN CHILDREN.
7.) LYME DISEASE LATE STAGE: MENINGITIS, OCULOPATHY,
IRIDOCYCLITIS, IRITIS,UVEITIS.
A.) LYME MENINGITIS.
B.) LYME OCULOPATHY.
C.) LYME IRIDOCYCLITIS, IRITIS AND UVEITIS.
8.) LYME DISEASE SECONDARY AND LATE STAGE: NEPHRITIS, HEPATITIS,
LYMPHADENOPATHY, MYOSITIS AND OTHER.
A.) LYME NEPHRITIS.
B.) LYME HEPATITIS.
C.) LYME LYMPHADENOPATHY.
D.) LYME MYOSITIS.
E.) OTHER CONDITIONS:
- PERPLEXING SYMPTOMS.
- PANCYTOPENIA.
- EYE SYMPTOMS.
9.) .) LYME DISEASE LATE STAGE AND CARDIOVASCULARY DISEASE.
A.) AORTIC ANEURYSM.
B.) ANEURYSM OF CORONARY ARTERIES.
C.) LATE ENDOCARDITIS.
D.) CARDITIS.
E.) ATRIOVENTRICULAR BLOCK.
10.) LYME DISEASE LATE STAGE, NEURO-BORRELIOSIS, NEURITIS OR
NEUROPATHY, MENINGOVASCULAR, NB WITH CEREBRAL INFARCTS, LYME
PARKINSONISM, LYME ENCEPHALITIS.
A.) NEUROBORRELIOSIS (NB) LATE SYMPTOMS.
B.) NEURITIS OR LATE NEUROPATHY.
C.) NEUROBORRELIOSIS (NB) MENINGOVASCULAR WITH CEREBRAL INFARCTS.
D.) INTRACRANEAL ANEURYSM.
E.) PARKINSONISM.
F.) LATE ENCEPHALITIS.
G.) STROKE DUE TO NEUROBORRELIOSIS.
H.) NEUROBORRELIOSIS (NB) UNSPECIFIC SYMPTOMS:
- LATE LYME DISEASE (NEUROBORRELIOSIS: COMPARISON AND EVIDENCE
OF THE SPIROCHETES AND LATE NEUROSYPHILIS.
- EVIDENCE BETWEEN THE INFECTION OF SPIROCHETES AND ALZHEIMER'S
DISEASE.
11.) LYME DISEASE: NEUROBORRELIOSIS, LATE LYME
MENINGOENCEPHALITIS OR MENINGOMYELOENCEPHALITIS.
12.) LYME DISEASE LATE STAGE: ATROPHIC FORM OF
MENINGOENCEPHALITIS WITH DEMENTIA, SUBACUTE PRESENILE DEMENTIA
AND
NEUROPSYCHIATRIC MANIFESTATIONS.
13.) LYME DISEASE: LATE STAGE: BONE,
JOINT AND MUSCULOSKELETAL MANIFESTATIONS
14.) LYME DISEASE, LATE STAGE:
OCULOPATHY, LIVER, KIDNEY AND RESPIRATORY MANIFESTATIONS.
A.) OCULOPATHY.
B.) LIVER AND OTHER VISCERAS.
C.) KIDNEY AND URETER.
D.) BRONCHIA AND LUNGS.
15.) LYME DISEASE, LATENT STAGE, UNESPICIFIED
A.) INFECTION OF THE CENTRAL NERVOUS SYSTEM.
B.) SIMPLE HERPES TYPE 1.
C.) DISEASES BY SPIROCHETES OF THE CENTRAL NERVOUS SYSTEM.
This CLASSIFICATION that you have just read is a summary of
the 280
BIBLIOGRAPHIC REFRENCES that I describe below which
you can find in the best scientific DATABASES such as
PUBMED, MEDSCAPE, LILACS etc, if you have some doubt
COPY and PASTE of any of them, put it in your browser and
you will get the EXACT information on the mentioned DATABASES.
As you can see, there are enough EVIDENCES, to
UPDATE the
CODES OF
LYME DISEASE
in all the DATABASES systems of the PLANET, to
give a
TOTAL coverage to the diagnosis and treatment of this
disease that in my particular way of seeing is becoming the
NEW PLAGUE OF THE 21ST CENTURY.
But this does not end
here, suddenly you think that some details are missing, some
or several questions, which I will explain in the
NEXT EDITION:
LYME'S DISEASE, SYPHILIS AND LEPROSY, THE MISSING LINK.
DO NOT MISS
IT !!!
In the references the facts ...
Greetings to all
Dr. Jose Lapenta.
EDITORIAL ESPAÑOL
=================
Hola amigos de la red DERMAGIC te trae hoy otro tema
interesante sobre la muy bien conocida ERITEMA
MIGRANS o ENFERMEDAD DE LYME, transmitida por la
picadura de una
GARRAPATA, del genero IXODES siendo el agente
causal una ESPIROQUETA,
bien conocida como BORRELIA
BURDORGFERI, descrita por primera vez por
WILLY BURGDORFER en el año 1.981, y previamente
conocida como ARTRITIS DE LYME. Hoy te traigo
LOS CODIGOS DE LA ENFERMEDAD DE LYME.
Actualmente a nivel mundial la ENFERMEDAD DE LYME
se ha convertido en un gran problema de salud pública,
debido al aumento anual de los casos, que en los
Estados unidos asciende a unos
380.000, casos nuevos anuales,
2 veces más que
el cáncer de mama y
6 veces más que el SIDA,
y mas allá de esto, la falta de modernización de los
CODIGOS DE LA ENFERMEDAD
a nivel de
SOFTWARE o DIGITAL, Estos no aparecen actualmente y
deben ser reconocidos para que los pacientes
puedan ser tratadosr a tiempo.
Los eventos que presento a continuación
están altamente relacionados con esta falta de
"CODIFICACIÓN" de la
ENFERMEDAD DE LYME y sus diferentes formas de
manifestarse clínicamente:
1.) DIFICULTAD PARA HACER EL DIAGNOSTICO:
=======================================
Ya bien es conocido que algunos TEST, para diagnosticar
la enfermedad dan como resultado "NEGATIVO" por
la habilidad que tiene el agente causal, la
espiroqueta BORRELIA
de "esconderse (BIOFILM) ante las pruebas
diagnosticas. Muchos pacientes con síntomas de
diferentes enfermedades como
MENINGITIS, ARTRITIS, y
FIEBRE RECURRENTE, en etapas tardías se
descubre que son LYME "POSITIVOS"
luego de hacerse múltiples pruebas para el
diagnostico,
perdiéndose un TIEMPO VALIOSO para iniciar un
tratamiento adecuado, y lo peor es que el desarrollo
crónico de estos síntomas, daa la calidad de vida de los
pacientes que son desasistidos por no tener UN
DIAGNOSTICO ESPECIFICO.
2.) RESISTENCIA AL TRATAMIENTO CONVENCIONAL:
============================================
Otro de los aspectos a considerar es que la
BORRELIA y sus especies con el tiempo han
desarrollado una "GRAN
RESISTENCIA" a la terapia convencional con
los consabidos tratamientos antibióticos: MINOCICLINA,
DOXICICLINA, AMOXICILINA, CEFUROXIMA, y OTROS,
llevando a los pacientes a la desesperación al
producirse la cronificación de los síntomas. La
ENFERMEDAD DE LYME tiene
CUATRO ETAPAS CLASICAMENTE conocidas:
INICIAL (I), SECUNDARIA (II), TARDIA (III) Y CRONICA
(IV).
3.) LA FALTA DE
MODERNIZACION DE LOS CODIDIGOS PARA LA ENFERMEDAD DE
LYME:
=====================================================================
En este mundo moderno y GLOBALIZADO, la
digitalización y la informática se han convertido en
elementos esenciales y todo o casi todo TIENE
UN CODIGO, aun las
ENFERMEDADES a nivel de software, y en el caso de la
ENFERMEDAD DE LYME estos deben ser
ACTUALIZADOS, y
esto se hace en base a las EVIDENCIAS REPORTES, ESTUDIOS
Y PUBLICACIONES de las distintas manifestaciones de la
enfermedad.
Entonces te estarás preguntando porque la
ENFERMEDAD DE LYME necesita la
actualización de sus CODIGOS?
Si tú te metes en la Organización Mundial de La
Salud (WHO) y buscas LA ENFERMEDAD DE LYME, solo
encontraras DOS (2) menciones en el tema
ZOONOSIS, transmisión por GARRAPATAS:
LYME DISEASE y FIEBRE
RECURRENTE (BORRELIOSIS), y los últimos
reportes relevantes en cuanto a estudios de la
enfermedad por la OMS datan de los años 1.993 y 1.995:
1.) WHO Workshop on Lyme Borreliosis Diagnosis and
Surveillance. Warsaw, Poland, 20-22 June 1995, Ref:
WHO/CDS/VPH/95.141:
Los países involucrados fueron:
Austria, Bulgaria, Republica
Checa, Dinamarca, Yugoslavia, Francia, Hungría, Irlanda,
Japón< Holanda, Polonia, Rusia, Suecia, Suiza, Reino
Unido y Estados
Unidos.
2.) Report of a WHO Workshop on Lyme Borreliosis.
Piestany, Slovak Republic, 6 October 1993, Ref: WHO/CDS/VPH/93.132:
Los países involucrados:
Alemania, Eslovaquia y
Estados Unidos. Si te lees esos
reportes podrás notar que están
TOTALMENTE DESACTUALIZADOS
en cuanto a la REALIDAD de la ENFERMEDAD DE LYME hoy día.
Y yo como siempre te voy a dar la respuesta:
Te voy a colocar acá mas de 270
REFERENCIAS BIBLIOGRAFICAS
clasificadas en base a las distintas manifestaciones de
LA ENFERMEDAD DE LYME
o LYME BORRELIOSIS
que son suficientes para RECONOCER que mas allá de
"ENFERMEDAD DE LYME" Y
"FIEBRE RECURRENTE (BORRELIOSIS)
hay otras manifestaciones de la BORRELIOSIS que deben
ser CODIFICADAS,
DIGITALIZADAS, para darle una
total cobertura a la
ENFERMEDAD y búsqueda de sus manifestaciones
clínicas.
Esta "AUSENCIA" de
CODIGOS provoca que
muchos pacientes portadores de LYME no
sean atendidos
ADECUADAMENTE, pues NO
"APARECEN EN EL SISTEMA" con sus respectivas
consecuencias.
Aquí me hago la INOCENTE pregunta, esto que ocurre es
"DESCONOCIMIENTO" o
"INTENCIONADO"?
porque reconocer todos estos CODIGOS IMPLICARIA
más gasto publico por
parte del Estado y de las
compañías de seguros.
Aquí te pongo la CLASIFICACION y luego las referencias:
1.) ENFERMEDAD DE LYME CONGENITA:
Potencial infección del Feto
con posibilidad de Muerte:
- LYME BORRELIOSIS EN MUJER EMBARAZADA.
- ERLIQUIOSIS Y BORRELIOSIS EN MUJER EMBARAZADA.
- ORIGEN DE LAS INFECCIONES EN RECIEN NACIDOS MUERTOS.
- TRNASMISION INTRAUTERINA DE BORRELIA BURGDORFERI EN
PERROS.
2.) ENFERMEDAD DE LYME:
INFECCION PRIMARIA:
- RECIEN NACIDO MUERTO DE MUJER EMBARAZADA CON
ENFERMEDAD DE LYME.
- LYME BBORRELIOSIS, IMPLICACION PARA EL FETO.
- BORRELIOSIS FETAL, TOXEMIA DEL EMBARAZO Y MUERTE
FETAL.
- ERITEMA MIGRANS EN EL EMBARAZO.
- TRANSMISION MATERNO FETAL DE LA ENFERMEDAD DE LYME.
- BORRELIA BURDOGFERI EN RECION NACIDO.
A.) INFECCION PRIMARIA Y ERITEMA MIGRANS.
- ERITEMA MIGRANS PRIMARIO Y SECUNDARIO.
B.) INFECCION PRIMARIA SERONEGATIVA.
- ANTIGENOS NEGATIVOS CONTRA BORRELIA BURGDORFERI EN
FLUIDO CEREBRO ESPINAL EN ENFERMEDAD DE LYME NEUROLOGICA.
- ENFERMEDAD DE LYME SERONEGATIVA.
- NEUROBORRELIOSIS RECURRENTE CRONICA SERONEGATIVA.
3.) ENFERMEDAD DE LYME: INFECCION PERSISTENTE EN LA
ETAPA SECUNDARIA Y TARDIA:
- INFECCION PERSISTENTE A ANTIBIOTICOS DOXIXICLINA Y
AMOXICILINA.
- AISLAMIENTO DE BORRELIA BURGDORFERI DE IRIS OCULAR.
- SOBREVIVENCIA DE BORRELIA BURGDORFERI LUEGO DE
ANTIBIOTICOTERAPIA.
4.) ENFERMEDAD DE LYME: INFECCION SECUNDARIA Y TARDIA:
A.) MANIFESTACIONES CUTANEAS:
- LINFOCITOMA POR BORRELIA (BL).
- ACRODERMATITIS ATROFICA.
- GRANULOMA ANULAR.
- MORFEA.
- ESCLERODERMIA LOCALIZADA.
- LIQUEN ESCLEROSO Y ATROFICO.
B.) OTRAS MANIFESTACIONES CUTANEAS:
- INFILTRADO LINFOCITICO BENIGNO DE JESSNER KANOF.
- ACRODERMATITIS DE GIANOTTI CROSTI.
- ERITEMA MULTIFORME ATIPICO.
- VASCULITIS URTICARIANA.
5.) ENFERMEDAD DE LYME DE LA PIEL Y MEMBRANAS MUCOSAS:
- ASOCIACION DE LA ENFERMEDAD DE LYME CON LA ENFERMEDAD
DE MORGELLON.
- ALOPECIA DIFUSA.
- ESCLERODERMIA EN GOLPE DE SABLE.
- PSEUDOPELADA DE BROCQ.
6.) ENFERMEDAD DE LYME: OTRAS
LESIONES:
- ANETODERMA.
- ERITEMA MIGRANS PRIMARIO Y SECUNDARIO EN NIÑOS.
7.) ENFERMEDAD DE LYME
SECUNDARIA Y TARDIA:
MENINGITIS, OCULOPATIA, IRIDOCICLITIS , IRISTIS, UVEITIS.
A.) LYME MENINGITIS.
B.) LYME OCULOPATIA.
C.) LYME IRIDOCICLITIS, IRITIS Y UVEITIS.
8.) ENFERMEDAD DE LYME:
NEFRITIS SECUNDARIA Y TARDIA,
HEPATITIS, LINFADENOPATIA, MIOSITIS Y OTRAS.
A.) LYME NEFRITIS.
B.) LYME HEPATITIS.
C.) LYME LINFADENOPATIA.
D.) LYME MIOSITIS.
E.) OTRAS CONDICIONES:
- SINTOMAS PERPLEJOS.
- PANCITOPENIA.
- SINTOMAS OCULARES.
9.) ENFERMEDAD DE LYME TARDIA:
MANIFESTACIONES
CARDIOVASCULARES:
A.) ANEURISMA AORTICO.
B.) ANEURISMA DE ARTERIAS CORONARIAS.
C.) ENDOCARDITIS TARDIA.
D.) CARDITIS.
E.) BLOQUEO ATRIOVENTRICULAR.
10.) ENFERMEDAD DE LYME:
NEUROBORRELIOSIS TARDIA (NB),
NEURITIS O NEUROPATIA, NEUROBORRELIOSIS (NB) CON
INFARTOS CEREBRALES, PARKINSONISMO Y ENCEFALITIS.
A.) NEUROBORRELIOSIS (NJB) TARDIA SINTOMATICA.
B.) NEURITIS O NEUROPATIA TARDIA.
C.) NEUROBORRELIOSIS (NB) MENINGOVASCULAR CON INFARTOS
CEREBRALES.
D.) ANEURISMA INTRACRANEANO.
E.) PARKINSONISMO.
F.) ENCEFALITIS TARDIA.
G.) EMBOLIA POR NEUROBORRELIOSIS.
H.) NEUROBORRELIOSIS (NB) SINTOMAS INESPECIFICOS:
- ENFERMEDAD DE LYME TARDIA (NEUROBORRELIOSIS:
COMPARACION Y EVIDENCIA DE LAS ESPIROQUETAS Y LA
NEUROSIFILIS TARDIA.
- EVIDENCIAS ENTRE LA INFECCION POR ESPIROQUETAS Y LA
ENFERMEDAD DE ALZHEIMER.
11.) ENFERMEDAD DE LYME
TARDIA:
NEUROBORRELIOSIS, MENINGOENCEFALITIS O
MENINGOMIELOENCEFALITIS TARDIA.
12.) ENFERMEDAD DE LYME
TARDIA:
FORMA ATROFICA DE
MENINGOENCEFALITIS CON DEMENCIA Y DEMENCIA SUBAGUDA
PRESENIL Y MANIFESTACIONES NEUROSIQUIATRICAS.
13.) ENFERMEDAD DE LYME
TARDIA: HUESOS,
ARTICULACIONES Y MANIFESTACIONES MUSCULO ESQUELETICAS.
14.) ENFERMEDAD DE LYME
TARDIA: OCULOPATIA,
HIGADO, RIÑON Y MANIFESTACIONES RESPIRATORIAS.
A.) OCULOPATIA.
B.) HIGADO Y OTRAS VISCERAS.
C.) RIÑON Y URETER.
D.) BRONQUIOS Y PULMONES.
15.) ENFERMEDAD DE LYME
LATENTE: SINTOMAS
INESPECIFICOS.
A.) INFECCION DEL SISTEMA NERVIOSO CENTRAL.
B.) HERPES SIMPLE TIPO 1.
C.) ENFERMEDADES POR ESPIROQUETAS DEL SISTEMA NERVIOSO
CENTRAL.
Esta CLASIFICACION que acabas de leer es un resumen
de las 280 REFERENCIAS
BIBLIOGRAFICAS que te describo abajo las
cuales puedes encontrar en las mejores BASES DE DATOS
cientificas como
PUBMED, MEDSCAPE, LILACS etc, si tienes
alguna duda has un COPIA y PEGA de cualquiera de
ellas, la colocas en tu navegador y obtendrás la
información EXACTA en las mencionadas BASES DE DATOS.
Como podrás ver, existen suficientes EVIDENCIAS, para
ACTUALIZAR los
CODIGOS DE LA
ENFERMEDAD DE LYME en todos los sistemas
INFORMATICOS DEL PLANETA, para darle una
cobertura TOTAL al diagnostico y tratamiento
de esta enfermedad que a mi modo particular de ver se
está convirtiendo
en la NUEVA PLAGA
del SIGLO XXI.
Pero esto no termina aqui, de pronto piensas que
faltan algunos detalles, algunas o varias interrogantes,
las cuales te voy a explicar en la
PROXIMA EDICION:
ENFERMEDAD DE LYME,
SIFILIS Y LEPRA, EL ESLABON PERDIDO.
NO TE LA PIERDAS !!!
En las referencias los hechos...
Saludos a Todos.
Dr. jose Lapenta.
==============================================================================
EBIBLIGRAPHICAL REFERENCES
/
REFERENCIAS BIBLIOGRAFICAS
==============================================================================
1.)
CONGENITAL LYME DISEASE /
Borrelia burgdorferi can potentially infect the fetus and cause adverse
fetal outcomes
==============================================================================
1.) Congenital infections and the nervous system. Pediatric Clinics of North
America. 1992;39(4):669–690. doi:10.1016/s0031-3955(16)38370-5. [PubMed]
Bale JF, Murph JR.
2.) [Human granulocytic ehrlichiosis co-incident with Lyme borreliosis in
pregnant woman--a case study] [in Polish] Przegl Epidemiol.
2004;58(2):289–94. [PubMed] Brzostek T.
3.) Lyme disease. In: Remington JS, Klein JO, eds. Infectious Diseases of
the Fetus and Newborn. 5th ed. Philadelphia: Saunders; 1995:447–528chap 11.
Gardner T.
4.) Lyme disease. In: Remington JS, Klein JO. Infectious diseases of the
fetus and newborn infant. 4th ed. Philadelphia: W B Saunders Co; December
13, 1994. Gardner T.
5.) The infectious origins of stillbirth. American Journal of Obstetrics and
Gynecology. 2003;189(3):861–873. doi:10.1067/s0002-9378(03)00470-8. [PubMed]
Goldenberg RL, Thompson C.
6.) Intrauterine transmission of Borrelia burgdorferi in dogs. American
Journal of Veterinary Research. 1993;54(6):882–890. [PubMed Gustafson JM,
Burgess EC, Wachal MD, Steinberg H.
7.) Stillbirth following maternal Lyme disease. N Y State J Med.
1987;11:615–616. [PubMed] MacDonald AB, Benach JL, Burgdorfer W.
8.) Gestational Lyme borreliosis. Implications for the fetus. Rheum Dis
Clin North Am. 1989;15(4):657–677. [PubMed] MacDonald AB.
9.) Human fetal borreliosis, toxemia of pregnancy, and fetal death.
Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical
Microbiology, Infectious Diseases, Virology, Parasitology.
1986;263(1-2):189–200. doi:10.1016/s0176-6724(86)80122-5. [PubMed] Macdonald
AB.
10.) Erythema migrans in pregnancy. Wiener klinische Wochenschrift.
2000;111:933–40. [PubMed] Maraspin V, Cimperman J, Lotric-Furlan S,
Pleterski-Rigler D, Strle F.
11.) Lyme disease during pregnancy. JAMA: The Journal of the American
Medical Association. 1986;255(24):3394. doi:10.1001/jama.1986.03370240064038.
PubMed Markowitz LE, Steere AC, Benach JL, Slade JD, Broome CV.
12.) Maternal-fetal transmission of the Lyme disease Spirochete, Borrelia
burgdorferi. Annals of Internal Medicine. 1985;103(1):67. doi:10.7326/0003-4819-103-1-67.
[PubMed]
Schlesinger PA, Duray PH, Burke BA, Steere AC, Stillman MT.
13.) Fetal outcome in Murine Lyme disease. Infection and Immunity.
1995;63(1):66–72. [PubMed] Silver RM, Yang L, Daynes RA, Branch WD, Salafia
CM, Weis JJ.
14.) Lyme disease and pregnancy outcome: A prospective s of two thousand
prenatal patients. American Journal of Obstetrics and Gynecology.
1993;169(2):367–374. doi:10.1016/0002-9378(93)90088-z. [PubMed] Strobino BA,
Williams CL, Abid S, Ghalson R, Spierling P.
15.) Borrelia burgdorferi in a newborn despite oral penicillin for Lyme
borreliosis during pregnancy. The Pediatric Infectious Disease Journal.
1988;7(4):286–288. doi:10.1097/00006454-198804000-00010. [PubMed]
==============================================================================
2.)
PRIMARY INFECTION ERYTHEMA MIGRANS
==============================================================================
16.) Clinical and epidemiological features of Lyme borreliosis in Bulgaria.
Wien Klin Wochenschr. 2004;116(1-2):42-6. [PubMed] Christova I, Komitova R.
17.) Contributions to the treatment of dermatologic manifestations of Lyme
borreliosis. Cutis. 1992 Jun;49(6):409-11. [PubMed] Hercogová J, Tománková
M, Barták P.
18.) Study Group for Lyme Borreliosis. Disease expression of Lyme
borreliosis in northeastern France. Eur J Clin Microbiol Infect Dis.
2001;20(4):225-30. [PubMed] Lipsker D, Hansmann Y, Limbach F, Clerc C,
Tranchant C, Grunenberger F, Caro-Sampara F, Attali P, Frey M, Kubina M,
Piémont Y, Sibilia J, Jaulhac B; GEBLY Study Group.
19.) Primary and secondary erythema migrans in central Wisconsin. Arch
Dermatol. 1993;129(6):709-16. [PubMed] Melski JW, Reed KD, Mitchell PD,
Barth GD.
20.) Epidemiology and clinical similarities of human spirochetal diseases.
Rev Infect Dis. 1989;11Suppl 6:S1460-9. Review type. [PubMed] Schmid GP.
==============================================================================
LYME
DISEASE, PRIMARY INFECTION, SERONEGATIVE
==============================================================================
21.) Detection of Borrelia burgdorferi antigens in cerebrospinal fluid.
Neurology 1993;43:1093-1097. [PubMed] Coyle PK, Deng Z, Schutzer SE, Belman
AL, Benach J, Krupp LB, Luft B.
22.) Detection of Borrelia burgdorferi-specific antigen in antibody-negative
cerebrospinal fluid in neurologic Lyme disease. Neurology.
1995;45(11):2010–2015. [PubMed]Coyle PK, Schutzer SE, Deng Z, et al.
23.) Seronegative Lyme Disease. Dissociation of T- and B-Lymphocyte
Responses to Borrelia burgdorferi. N Engl J Med 1988;319:1441-6.
[PubMed]Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly
MG.
24.) Tick inoculation in an eyelid region: report on five cases with one
complication of the orbital myositis associated with Lyme borreliosis. Klin
Oczna. 2006;108(4-6):220-4. [PubMed] Holak H1, Holak N, Huzarska M, Holak S.
25.) Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J
Ophthalmol. 1995;119(2):127-35. [PubMed]Karma A, Seppälä I, Mikkilä H,
Kaakkola S, Viljanen M, Tarkkanen A.
26.) Seronegative Chronic Relapsing Neuroborreliosis. Eur Neurol
1995;35:113-117. [PubMed] Lawrence C, Lipton RB, Lowy FD, Coyle PK.
==============================================================================
3.) LYME
DISEASE, PERSISTENT INFECTION IN SECONDARY AND LATE STAGE
==============================================================================
27.) Identification of novel activity against Borrelia burgdorferi
persisters using an FDA approved drug library. Emerg. Microbes Infect.
2014;3:e49. doi: 10.1038/emi.2014.53. [PMC free article] [PubMed] [Cross Ref]
Feng J., Wang T., Shi W., Zhang S., Sullivan D., Auwaerter P.G., Zhang Y.
28.) Borrelia burgdorferi detected by culture and PCR in clinical relapse of
disseminated Lyme borreliosis. Ann. Med. 1999;31:225–232. doi:
10.3109/07853899909115982. [PubMed] [Cross Ref] Oksi J., Marjamaki M.,
Nikoskelainen J., Viljanen M.K.
29.) First Isolation of Borrelia burgdorferi from an Iris Biopsy. J Clin
Neuro-ophthalmol 1993;13:155-161. [PubMed]
Preac-Mursic V, Weber K, Pfister HW, Wilske B, Gross B, Baumann A, Prokop J.
Survival of Borrelia burgdorferi in Antibiotically Treated Patients with
Lyme borreliosis. Infection 1989;17:355-359. [PubMed] Preac-Mursic V,
Pfister HW, Spiegel H, Burk R, Wilske B, Reinhardt S, Bohmer R.
30.) Cultivation of Borrelia burgdorferi from joint fluid three months after
treatment of facial palsy due to Lyme borreliosis. J. Infect. Dis.
1988;158:905–906. doi: 10.1093/infdis/158.4.905. [PubMed] [Cross Ref
Schmidli J., Hunziker T., Moesli P., Schaad U.B.
==============================================================================
4.) LYME
DISEASE, PERSISTENT INFECTION IN SECONDARY AND LATE STAGE, CUTANEOUS LESIONS,
BORRELIAL LYMPHOCYTOMA
==============================================================================
31.) Borrelial Lymphocytoma in Children. Pediatr Infect Dis J.
2015;34(12):1319-22. [PubMed] Arnež M, Ružic-Sabljic E.
32.) Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic,
immunophenotypic, and molecular study of 106 cases. J Cutan Pathol.
2004;31(3):232-40. [PubMed] Colli C, Leinweber B, Müllegger R, Chott A, Kerl
H, Cerroni L.
33.) Clinical spectrum of skin manifestations of Lyme borreliosis in 204
children in Austria. Acta Derm Venereol. 2015;95(5):565-71. [PubMed] Glatz
M, Resinger A, Semmelweis K, Ambros-Rudolph CM, Müllegger RR.
34.) B.Borrelia burgdorferi infection and cutaneous Lyme disease, Mexico.
Emerg Infect Dis. 2007;13(10):1556-8. [PubMed] Gordillo-Pérez G, Torres J,
Solórzano-Santos F, de Martino S, Lipsker D, Velázquez E, Ramon G, Onofre M,
Jaulhac
35.) Therapy of Lyme borreliosis in children. Infection. 1996;24(2):170-3. [PubMed]MKrbkova
L, Stanek G.
36.) Species of Borrelia burgdorferi complex that cause borrelial
lymphocytoma in France. Br J Dermatol. 2009;161(1):174-6. [PubMed]
Lenormand C, Jaulhac B, De Martino S, Barthel C, Lipsker D.
37.) Solitary borrelial lymphocytoma in adult patients. Wien Klin Wochenschr.
2002;114(13-14):515-23. [PubMed] Maraspin V, Cimperman J, Lotric-Furlan S,
Ruzic-Sabljic E, Jurca T, Picken RN, Strle F.
38.) Borrelial Lymphocytoma in Adult Patients. Clin Infect Dis.
2016;63(7):914-21. [PubMed] Maraspin V, Nahtigal Klevišar M, Ružic-Sabljic
E, Lusa L, Strle F.
39.) Chemokine signatures in the skin disorders of Lyme borreliosis in
Europe: predominance of CXCL9 and CXCL10 in erythema migrans and
acrodermatitis and CXCL13 in lymphocytoma. Infect Immun. 2007;75(9):4621-8.
[PubMed] Müllegger RR, Means TK, Shin JJ, Lee M, Jones KL, Glickstein LJ,
Luster AD, Steere AC.
40.) Treatment of borrelial lymphocytoma. Infection. 1996;24(1):80-4. [PubMed]
Strle F, Maraspin V, Pleterski-Rigler D, Lotric-Furlan S, Ruzic-Sabljic E,
Jurca T, Cimperman J.
===============================================================
LYME
DISEASE AND ACRODERMATITIS ATROPHICANS
===============================================================
41.) Cutaneous manifestations of Lyme borreliosis. Infection. 1991
Jul-Aug;19(4):284-6. [PubMed] Aberer E, Klade H.
42.) Borrelia burgdorferi sensu lato strains isolated from cutaneous Lyme
borreliosis biopsies differentiated by pulsed-field gel electrophoresis.
Scand J Infect Dis. 1996;28(6):583-9. [PubMed] Busch U, Hizo-Teufel C,
Böhmer R, Fingerle V, Rössler D, Wilske B, Preac-Mursic V.
43.) Further evidence for Borrelia burgdorferi infection in morphea and
lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest
Dermatol. 1993;100(5):717-20. [PubMed] Schempp C, Bocklage H, Lange R,
Kölmel HW, Orfanos CE, Gollnick H.
44.) Molecular subtyping of Borrelia burgdorferi in erythema migrans and
acrodermatitis chronica atrophicans. J Invest Dermatol. 1994;103(1):19-22. [PubMed]
Wienecke R1, Zöchling N, Neubert U, Schlüpen EM, Meurer M, Volkenandt M.
45.) Acrodermatitis chronica atrophicans--a spirochetosis. Clinical and
histopathological picture based on 32 patients; course and relationship to
erythema chronicum migrans Afzelius. Am J Dermatopathol. 1986;8(3):209-19. [PubMed]
Asbrink E, Brehmer-Andersson E, Hovmark A.
================================================================
LYME
DISEASE AND GRANULOMA ANNULARE, MORPHEA, LOCALIZED SCLERODERMA,
LICHEN SCLEROSUS AND ATROPHICUS.
===============================================================
46.) Amplification of DNA of Borrelia burgdorferi in urine samples of
patients with granuloma annulare and lichen sclerosus et atrophicus.
1999;135(2):210-2. [PubMed] Aberer E, Schmidt BL, Breier F, Kinaciyan T,
Luger A.
47.)Localized scleroderma associated with Borrelia burgdorferi infection.
Clinical, histologic, and immunohistochemical observations. J Am Acad
Dermatol. 1993;29(2 Pt 1):190-6. [PubMed] Buechner SA, Winkelmann RK,
Lautenschlager S, Gilli L, Rufli T.
48.) Morphoea: a manifestation of infection with Borrelia species? Br J
Dermatol. 2007;157(6):1189-98. [PubMed] Eisendle K, Grabner T, Zelger B.
49.) Chronic borreliosis presenting with morphea- and lichen sclerosus et
atrophicus-like cutaneous lesions. a case report. Dermatology.
2001;202(4):373-5. [PubMed] Kaya G, Berset M, Prins C, Chavaz P, Saurat JH.
50.) Diagnosis of Lyme disease based on dermatologic manifestations. Ann
Intern Med. 1991;114(6):490-8. [PubMed] Malane MS, Grant-Kels JM, Feder HM
Jr, Luger SW.
51.) Eruzione a tipo pitiriasi lichenoide con perifollicoliti in corso di
borreliosi di Lyme. Eur J Pediat Dermatol. 1994;4:77–80. Menni S, Pistritto
G, Gelmetti C, Stanta G, Trevisan G.
52.) Evidence for Borrelia burgdorferi in morphea and lichen sclerosus. Int
J Dermatol. 2000;39(4):278-83. [PubMed] Ozkan S, Atabey N, Fetil E, Erkizan
V, Günes AT.
53.) Further evidence for Borrelia burgdorferi infection in morphea and
lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest
Dermatol. 1993;100(5):717-20. [PubMed] Schempp C, Bocklage H, Lange R,
Kölmel HW, Orfanos CE, Gollnick H.
54.) Morphea Borrelia burgdorferi and localized scleroderma. Clin Dermatol.
1994;12(3):475-9. [ScienceDirect] Trevisan G, Rees DH, Stinco G.
55.) Lyme Borreliosis and Skin. Indian J Dermatol. 2013;58(3): 167–174. doi:
10.4103/0019-5154.110822 [PubMed] Vasudevan B, Chatterjee M.
56.) Extragenital lichen sclerosus with aetiological link to Borrelia. MJAFI.
2011;67:370–3. [PubMed] Vasudevan B, Sagar A, Bahal A, Mohanty AP.
57.) Is Localized Scleroderma Caused by Borrelia burgdorferi? Vector Borne
Zoonotic Dis. 2016;16(9):577-80. [PubMed]Zinchuk AN, Kalyuzhna LD, Pasichna
IA.
==================================================================
LYME
DISEASE AND OTHER CUTANEOUS MANIFESTATIONS
=================================================================
58.) Benign lymphocytic infiltration (Jessner-Kanof): another manifestation
of borreliosis? J Am Acad Dermatol. 1989;21(4 Pt 1):795-7. [PubMed] Abele
DC, Anders KH, Chandler FW.
59.) Infantile acrodermatitis of Gianotti-Crosti and Lyme borreliosis. Acta
Derm Venereol. 1996;76(3):242-3. [PubMed]Baldari U, Cattonar P, Nobile C,
Celli B, Righini MG, Trevisan G.
60.) Polymerase chain reaction of Borrelia burgdorferi flagellin gene in
Shulman syndrome. Dermatology. 1996;192(2):136-9. [PubMed] Hashimoto Y,
Takahashi H, Matsuo S, Hirai K, Takemori N, Nakao M, Miyamoto K, Iizuka H.
61.) Atypical erythema multiforme occurring at the early phase of Lyme
disease? Acta Derm Venereol. 2000;80(3):222. [PubMed] Lesire V, Machet L,
Toledano C, de Muret A, Maillard H, Lorette G, Vaillant L.
62.) Urticarial vasculitis and Lyme disease. J Am Acad Dermatol. 1990;22(6
Pt 1):1114-6. [PubMed] Olson JC, Esterly NB.
=====================================================================
5..) LYME
DISEASE OF SKIN AND MUCOUS MEMBRANES
=====================================================================
63.) Lyme borreliosis: aspects of tick-borne Borrelia burgdorferi infection
from a dermatologic viewpoint. Semin Dermatol. 1990;9(4):277-91. [PubMed]Asbrink
E, Hovmark A.
64.) Exploring the association between Morgellons disease and Lyme disease:
identification of Borrelia burgdorferi in Morgellons disease patients. BMC
Dermatol. 2015 Feb 12;15:1. [PubMed] Middelveen MJ, Bandoski C, Burke J,
Sapi E, Filush KR, Wang Y, Franco A, Mayne P, Stricker RB.
65.) Lyme Borreliosis and Skin. Indian J Dermatol. 2013; 58(3):167–174. [PubMed]
Vasudevan B, Chatterjee M.
=====================================================================
LYME
DISEASE AND ALOPECIA
=====================================================================
66.) Diffuse reversible alopecia in patients with Lyme meningitis and
tick-borne encephalitis. Wiener klinische Wochenschrift. 2000;111:976–7. [PubMed]
Cimperman J, Maraspin V, Lotric-Furlan S, Ruzic-Sabljic E, Avsic-Zupanc T,
Strle F.
67.) Lichen sclerosus et atrophicans, scleroderma en coup de sabre and Lyme
borreliosis. Dermatol Reports. 2011;28;3(2):e27.
doi: 10.4081/dr.2011.e27. [PubMed] Gubertini N, Bonin S, Trevisan G.
68.) Lyme disease in central Europe. Curr Opin Infect Dis. 2001;14(2):133-7.
[PubMed] Hercogová J, Brzonova I.
69.) [Pseudopelade Brocq--possible sequela of stage III borrelia infection?]
[in German]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und
verwandte Gebiete. 1999;49(11):835–7. [PubMed] Schwarzenbach R, Djawari D.
=====================================================================
6.) LYME
DISEASE AND OTHER LESIONS
=====================================================================
70.) Anetoderma: another facet of Lyme disease? J Am Acad Dermatol.
2003;48(5 Suppl):S86-8. [PubMed]Bauer J1, Leitz G, Palmedo G, Hügel H.
71.) Clinical spectrum of skin manifestations of Lyme borreliosis in 204
children in Austria. Acta Derm Venereol. 2015;95(5):565-71. [PubMed] Glatz
M, Resinger A, Semmelweis K, Ambros-Rudolph CM, Müllegger RR.
72.) Primary and secondary erythema migrans in central Wisconsin. Arch
Dermatol. 1993;129(6):709-16. [PubMed] Melski JW, Reed KD, Mitchell PD,
Barth GD.
=====================================================================
7.) LYME
DISEASE LATE STAGE:
MENINGITIS,
OCULOPATHY, IRIDOCYCLITIS, IRITIS,UVEITIS
=====================================================================
73.) Neurologic manifestations in children with Lyme disease. Pediatrics.
1995;96:1053-1056. [PubMed] Bingham PM, Galetta SL, Athreya B, Sladky J.
74.)Chronic and recurrent meningitis. Pract Neurol. 2008 Dec;8(6):348-61.
Review doi: 10.1136/jnnp.2008.157396. [PubMed] Ginsberg L, Kidd D.
75.) Pachner AR. Early disseminated Lyme disease: Lyme meningitis. Am J Med.
1995 Apr 24;98(4A):30S-37S; discussion 37S-43S. [PubMed] Pachner AR.
76.) Clinical manifestations of Lyme disease. Zentralbl Bakteriol Mikrobiol
Hyg A. 1986;263(1-2):201-5.[PubMed] Steere AC, Bartenhagen NH, Craft JE,
Hutchinson GJ, Newman JH, Pachner AR, Rahn DW, Sigal LH, Taylor E, Malawista
SE.
77.) Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J
Ophthalmol. 1995;119(2):127-35. doi:10.1016/s0002-9394(14)73864-4. [PubMed]
Karma A, Seppälä I, Mikkilä H, Kaakkola S, Viljanen M, Tarkkanen A.
78.) The expanding clinical spectrum of ocular lyme borreliosis.
Ophthalmology 2000;107:581-587. [PubMed] Mikkilä HO, Seppala IJ, Viljanen
MK, Peltomaa MP, Karma A.
79.) Ocular manifestations of tick-borne diseases. Surv Ophthalmol.
2016;61(6):726-744. Review. doi: 10.1016/j.survophthal.2016.03.011. [PubMed]
Raja H, Starr MR, Bakri SJ.
80.) The eye and tick-borne disease in the United States. Curr Opin
Ophthalmol. 2016;27(6):530-537. Review. DOI: 10.1097/ICU.0000000000000308 [PubMed]
Sathiamoorthi S, Smith WM.
81.) Iritis and papillitis as a primary presentation of Lyme disease. Ann
Ophthalmol. 1990;22(1):24-5. [PubMed] Boutros A, Rahn E, Nauheim R.
82.) [Ocular manifestations of Lyme borreliosis in northwest Croatia]. Lijec
Vjesn. 2004;126(5-6):124-8. [Article in Croatian] [PubMed] Golubic D,
Vinkovic T, Turk D, Hranilovic J, Slugan I.
83.) Ocular Lyme borreliosis. Am J Ophthalmol. 1989;15;108(6):651-7. [PubMed]
Winward KE, Smith JL, Culbertson WW, Paris-Hamelin A.
=====================================================================
8.) LYME
DISEASE SECONDARY AND LATE STAGE:
NEPHRITIS, HEPATITIS, LYMPHADENOPATHY, MYOSITIS AND OTHER.
=====================================================================
84.) Lyme disease and glomerulonephritis. Ir Med J. 2017;92(5):372. [PubMed]
Kelly B, Finnegan P, Cormican M, Callaghan J.
85.) Comment on 'Membranous glomerulonephritis secondary to Borrelia
burgdorferi infection presenting as nephrotic syndrome'. Nephrology Dialysis
Transplantation. 2010;25(5):1723-1727. doi:10.1093/ndt/gfq028. [PubMed]
Kirmizis D, Chatzidimitriou D.
86.) Renal Manifestations of Lyme Disease: Interplay between Infection and
Immunostimulation. In: Holmgren A, Borg G, ed. Handbook Of Disease
Outbreaks: Prevention, Detection And Control. 1st ed. New York: Nova Science
Publishers Inc; 2010. https://www.novapublishers.com/catalog/product_info.php?products_id=11009]
Kirmizis D, Chatzidimitriou D.
87.) MPGN secondary to lyme disease. American Journal of Kidney Diseases.
2004;43(3):544-551. doi:10.1053/j.ajkd.2003.11.014. [PubMed] Kirmizis D,
Efstratiadis G, Economidou D, Diza-Mataftsi E, Leontsini M, Memmos D.
88.) Minimal-Change Disease Secondary toBorrelia burgdorferiInfection. Case
Reports in Nephrology. 2012;2012:1-3. doi:10.1155/2012/294532. [PubMed]
Kwiatkowska E, Golembiewska E, Ciechanowski K, Kedzierska K.
89.) Lyme disease-associated glomerulonephritis. Nephrology Dialysis
Transplantation. 2011;26(9):3054-3056. doi:10.1093/ndt/gfr335. [PubMed] Mc
Causland F, Niedermaier S, Bijol V, Rennke H, Choi M, Forman J.
90.) Membranous glomerulonephritis secondary to Borrelia burgdorferi
infection presenting as nephrotic syndrome. Clinical Kidney Journal.
2009;3(1):105-106. doi:10.1093/ndtplus/sfp160. [PubMed] Papineni P, Doherty
T, Pickett T, Toth T, Boddana P.
91.) MPGN and Nephrotic Syndrome (NS) Secondary to Lyme Disease (LD).
American Journal of Kidney Diseases. 2008;51(4):B83.
doi:10.1053/j.ajkd.2008.02.231. [http://www.ajkd.org/article/S0272-6386(08)00402-2/abstract]
Rawal B, Rovner L, Thakar C, Pollock J.
92.) Penetration of endothelial cell monolayers by Borrelia burgdorferi,
Infect Immun , 1989, vol. 57 (pg. 1626-8) [PubMed] Comstock LE, Thomas DD.
93.) Goellner MH, Agger WA, Burgess JH, Duray PH. Hepatitis due to recurrent
Lyme disease, Ann Intern Med , 1988, vol. 108 (pg. 707-8) [PubMed]Goellner
MH, Agger WA, Burgess JH, Duray PH.
94.) Lyme borreliosis in the severe combined immunodeficiency (scid) mouse
manifests predominantly in the joint, heart and liver, Am J Pathol, 1990,
vol. 137 (pg. 811-20) [PubMed] Schaible UE, Gay S, Museteanu C, et al.
95.) Gastrointestinal and Hepatic Manifestations of Tickborne Diseases in
the United States. Clin Infect Dis. 2002:34(9):1206-1212. DOI:https://doi.org/10.1086/339871
[PubMed] Zaidi SA, Singer C.
96.)[A reprospective analysis of 973 patients with lyme borreliosis in
Kuyavian-Pomeranian voivodship in 2000-2005]. [Article in Polish] Przegl
Epidemiol. 2012;66(4):581-6. [PubMed] Blazejewicz-Zawadziniska M, Brochocka
A, Lisinska J, Borowiecki M.
97.) Lymphoadenopathy during lyme borreliosis is caused by spirochete
migration-induced specific B cell activation. PLoS Pathog.
2011;7(5):e1002066. doi: 10.1371/journal.ppat.1002066. [PubMed] Tunev SS,
Hastey CJ, Hodzic E, Feng S, Barthold SW, Baumgarth N.
98.)[Clinico-epidemiologic characteristics of Lyme disease treated at the
Infectious Disease in Novy Sad 1993-1998]. [Article in Croatian] Med Pregl.
2001;54(9-10):470-5. [PubMed] Vukadinov J1, Canak G, Brkic S, Samardzija
NM, Aleksic-Dordevic M, Turkulov V, Cik-Nad E, Lalosevic V.
99.) Borrelia arthritis and chronic myositis accompanied by typical chronic
dermatitis. JBR-BTR. 2008;91(3):88-9. [PubMed] Brtkova J, Jirickova P,
Kapla J, Dedic K, Pliskova L.
100.) Orbital myositis associated with Borrelia burgdorferi (Lyme disease)
infection. Ophthalmology. 2004;111(5):1023-8. DOI:
10.1016/j.ophtha.2003.08.032. [PubMed] Carvounis PE, Mehta AP, Geist CE.
101.) Tick inoculation in an eyelid region: report on five cases with one
complication of the orbital myositis associated with Lyme borreliosis. Klin
Oczna. 2006;108(4-6):220-4. [PubMed] Holak H, Holak N, Huzarska M, Holak S.
102.) Lyme myositis. Arthritis Rheum. 2006;54(8):2697-700. [PubMed] Holmgren
AR, Matteson EL.
103.) Two cases of orbital myositis as a rare feature of lyme borreliosis.
Case Rep Infect Dis. 2011;2011:372470. doi: 10.1155/2011/372470. [PubMed]
Sauer A, Speeg-Schatz C, Hansmann Y.
104.) [Lyme disease could mimic dermatomyositis]. [Article in French] Rev
Med Interne. 2007 May;28(5):343-5. [PubMed] Waton J, Pinault AL, Pouaha J,
Truchetet F.
105.) Late Diagnosis of Early Disseminated Lyme Disease: Perplexing Symptoms
in a Gardener, J Am Board Fam Med May-June 2008 vol. 21 no. 3 234-236 [PubMed]
doi: 10.3122/jabfm.2008.03.070196 Brooke E. Salzman, MD, Amber Stonehouse,
MD and James Studdiford, MD
106.) Pancytopenia in Lyme disease. BMJ Case Rep. 2014;4;2014. pii:
bcr2013201079. doi: 10.1136/bcr-2013-201079. [PubMed] Mehrzad R, Bravoco J.
107.) The eye and tick-borne disease in the United States. Curr Opin
Ophthalmol. 2016 Nov;27(6):530-537. [PubMed] Sathiamoorthi S, Smith W.
=====================================================================
9.) LYME
DISEASE LATE STAGE AND CARDIOVASCULARY DISEASE.
=====================================================================
108.) Coronary aneurysm in Lyme disease: Treatment by covered stent.
International Journal of Cardiology. 2008;128(2):e72–e73.
doi:10.1016/j.ijcard.2007.04.163. [PubMed] Cuisset T, Hamilos M,
Vanderheyden M.
109.) Coronary artery aneurysm in two patients with long-standing Lyme
borreliosis. The Lancet. 1994;344(8932):1300-1301.
doi:10.1016/s0140-6736(94)90789-7. [PubMed] Gasser R, Watzinger N, Eber B et
al.
110.) Presence of Borrelia burgdorferi sensu lato antibodies in the serum of
patients with abdominal aortic aneurysms. Eur J Clin Microbiol Infect Dis.
2012 May;31(5):781-9. doi: 10.1007/s10096-011-1375-y. Epub 2011 Aug 13. [PubMed]
Hinterseher I1, Gäbel G, Corvinus F, Lück C, Saeger HD, Bergert H, Tromp G,
Kuivaniemi H.
111.)[Coronary aneurysm in a 69-year-old patient. Transthoracic
echocardiography]. Ultraschall in der Medizin - European Journal of
Ultrasound. 1995;16(04):200-202. doi:10.1055/s-2007-1003939. [PubMed]
Watzinger N, Fruhwald F, Schafhalter I et al.
112.) Ascending aortitis: a clinicopathological study of 21 cases in a
series of 300 aortic repairs. Pathology. 2014 Jun;46(4):296-305. doi:
10.1097/PAT.0000000000000096. [PubMed] Xu L1, Heath J, Burke A.
113.) Coronary artery aneurysm in two patients with long-standing Lyme
borreliosis. Borreliosis Study Group. Lancet. 1994;344:1300–1301. doi:
10.1016/S0140-6736(94)90789-7. [PubMed] [Cross Ref] Gasser R, Watzinger N,
Eber B, Luha O, Reisinger E, Seinost G, Klein W.
114.) Peroperative cardiogenic shock suggesting acute coronary syndrome as
initial manifestation of Lyme carditis. J Clin Anesth. 2016 Dec;35:430-433.
doi: 10.1016/j.jclinane.2016.08.005. Epub 2016 Oct 18. [PubMed] Clinckaert
C, Bidgoli S, Verbeet T, Attou R, Gottignies P, Massaut J, Reper P.
115.) Coronary aneurysm in Lyme Disease: treatment by covered stent. Int J
Cardiol. 2008 Aug 18;128(2):e72-3. [PubMed] Cuisset T, Hamilos M,
Vanderheyden M.
116.) [Coronary aneurysm in a 69-year-old patient. Transthoracic
echocardiography]. Ultraschall Med. 1995 Aug;16(4):200-2. German. [PubMed]
Watzinger N, Fruhwald FM, Schafhalter I, Hermann J, Luha O, Zweiker R,
Gasser R, Eber B, Klein W.
117.) [Complete atrioventricular block as the first clinical manifestation
of a tick bite (Lyme disease)] [in Italian]. Giornale italiano di
cardiologia (2006). 2011;12(3):214–6. [PubMed] Bacino L, Gazzarata M, Siri
G, Cordone S, Bellotti P.
118.) Peroperative cardiogenic shock suggesting acute coronary syndrome as
initial manifestation of Lyme carditis. Journal of Clinical Anesthesia.
2016;35:430–433. doi:10.1016/j.jclinane.2016.08.005. [PubMed] Clinckaert C,
Bidgoli S, Verbeet T, et al.
119.) [The Lyme carditis as a rare differential diagnosis to an anterior
myocardial infarction] [in German]. Zeitschrift für Kardiologie.
2002;91(12):1053–1060. doi:10.1007/s00392-002-0873-4. [PubMed] Dernedde S,
Piper C, Kühl U, et al.
120.) [Reversible complete heart block by re-infection with Borrelia
burgdorferi with negative IgM-antibodies] [in German]. Deutsche medizinische
Wochenschrift (1946). 2008;134:23–6. [PubMed]Guenther F, Bode C, Faber T.
121.) Lyme carditis: restitutio ad integrum documented by cardiac magnetic
resonance imaging. Cardiology in Review. 2004;12(4):185-187.
doi:10.1097/01.crd.0000123841.02777.5d. [PubMed] Karadag B, Spieker L,
Schwitter J et al.
122.) Manifestations of Lyme carditis. International Journal of Cardiology.
2017;232:24-32. doi:10.1016/j.ijcard.2016.12.169. [PubMed] Kostic T,
Momcilovic S, Perišic Z et al.
123.) Detection of Borrelia burgdorferi sensu lato in endomyocardial biopsy
specimens in individuals with recent-onset dilated cardiomyopathy. European
Journal of Heart Failure. 2012;14(6):588–596. doi:10.1093/eurjhf/hfs027. [PubMed]
Kubánek M, Šramko M, Berenová D, et al.
124.)[Lyme disease presenting as infarction pain. A case report] [in
French]. Archives des maladies du coeur et des vaisseaux.
2002;94(12):1419–22. [PubMed] Meimoun P, Sayah S, Benali T, et al.
125.) [Lyme carditis presenting as acute coronary syndrome: A case report]
[in Polish]. Kardiologia polska. 2008;66(4):420–5. [PubMed] Rostoff P,
Konduracka E, Massri E, et al.
126.) Detection of Borrelia bissettii in cardiac valve tissue of a patient
with Endocarditis and Aortic valve Stenosis in the Czech Republic. Journal
of Clinical Microbiology. 2008;46(10):3540–3543. doi:10.1128/jcm.01032-08. [PubMed]
Rudenko N, Golovchenko M, Mokracek A, et al.
127.) [Diagnosis and course of myocarditis: A survey in the medical clinics
of Zurich university hospital 1980 to 1998] [in German]. Schweizerische
medizinische Wochenschrift. 2000;130(36):1265–71. [PubMed] Sauvant G,
Bossart W, Kurrer M, Follath F.
128.) Borrelia burgdorferi as an etiologic agent in chronic heart failure?
Scandinavian journal of infectious diseases. Supplementum. 1991;77:85–7. [PubMed]
Stanek G, Klein J, Bittner R, Glogar D.
=====================================================================
10.) LYME
DISEASE LATE STAGE, NEURO-BORRELIOSIS,
NEURITIS OR NEUROPATHY, MENINGOVASCULAR, NB WITH CEREBRAL INFARCTS, LYME
PARKINSONISM, LYME ENCEPHALITIS.
=====================================================================
129.) Lyme disease –induced polyradiculopathy mimicking amyotrophic lateral
sclerosis. Inter J of Neuroscience. 2014;124(11):859–862.
doi:10.3109/00207454.2013.879582. [PubMed] Burakgazi AZ.
130.) Clinical and epidemiological features of Lyme borreliosis in Bulgaria.
Wien Klin Wochenschr. 2004;116(1-2):42-6. [PubMed] Christova I, Komitova R.
131.) Seronegative Chronic Relapsing Neuroborreliosis. Eur Neurol
1995;35:113-117. [PubMed] Lawrence C, Lipton RB, Lowy FD, Coyle PK.
132.) Genetic Analysis of Borrelia garinii OspA Serotype 4 Strains
Associated with Neuroborreliosis: Evidence for Extensive Genetic
Homogeneity. J Clin Microbiol. 1999;37(12): 3965–3970. [PubMed Central]
Marconi RT, Hohenberger S, Jauris-Heipke S, Schulte-Spechtel U, LaVoie CP,
Rößler D, Wilske B.
133.) [Clinical manifestations of neuroborreliosis in the Volga region].
[Article in Russian]. Ter Arkh. 2010;82(11):68-70. [PubMed] Nafeev AA,
Klimova LV.
134.) Avellis syndrome due to borreliosis. Eur J Neurol. 2007;14(1):112-4.
DOI: 10.1111/j.1468-1331.2006.01528.x. [PubMed] Habek M, Mubrin Z, Brinar
VV.
135.) Lyme disease: cause of a treatable peripheral neuropathy. Neurology.
1987;37(11):1700-6. [PubMed] Halperin JJ, Little BW, Coyle PK, Dattwyler
RJ.
136.) Retrobulbar optic neuritis: a complication of Lyme disease? J Neurol
Neurosurg Psychiatry. 2007;78(12): 1409–1410. doi: 10.1136/jnnp.2006.113761.
[PubMed Central] Krim E, Guehl D, Burbaud P, and LaguenyA.
137.) Unusual manifestations of nervous system Borrelia burgdorferi
infection. Arch Neurol. 1987;44(7):781-3. [PubMed] Midgard R, Hofstad H.
138.) Optic neuropathy in children with Lyme disease. Pediatrics.
200;108(2):477-81. [PubMed] Rothermel H, Hedges TR 3rd, Steere AC.
139.) Optic nerve involvement in Lyme disease. Curr Opin Ophthalmol.
2012;23(6):485-90. doi:10.1097/ICU.0b013e328358b1eb. (Pubmed) Träisk F,
Lindquist L.
140.) Stroke as an Unusual First Presentation of Lyme Disease. Case Rep
Neurol Med. 2015;2015:389081. doi: 10.1155/2015/389081. Epub 2015 Dec 16. [PubMed]
Almoussa M1, Goertzen A1, Fauser B1, Zimmermann CW1.
141.) Neuroborreliosis-associated cerebral vasculitis: long-term outcome and
health-related quality of life. J Neurol. 2013 Jun;260(6):1569-75. doi:
10.1007/s00415-013-6831-4. [PubMed] Back T1, Grünig S, Winter Y, Bodechtel
U, Guthke K, Khati D, von Kummer R.
142.) Cerebral sinuvenous thrombosis: a rare complication of Lyme
neuroborreliosis. Wiener klinische Wochenschrift. 2014;127(1-2):65-67.
doi:10.1007/s00508-014-0622-5. [PubMed] Blažina K, Miletic V, Relja M,
Bažadona D.
143.) The enlarging clinical spectrum of Lyme disease: Lyme cerebral
vasculitis, a new disease entity. Ann Emerg Med. 1990;19:572–6. [PubMed]
Brogan GX, Homan CS, Viccellio P.
144.) Lyme disease presenting as a stroke in the vertebrobasilar territory:
MRI. Neuroradiology. 1993;35:529–31. [PubMed] Defer G, Levy R, Brugieres P,
Postic D, Degos JD.
145.) Screening for neuroborreliosis in patients with stroke. Stroke.
1993;24:1393–6. [PubMed] Hammers-Berggren S, Grondahl A, Karlsson M, von
Arbin M, Carlsson A, Stiernstedt G.
146.) [Lyme disease from the neurologist's viewpoint]. [in German]. Schweiz
Med Wochenschr. 1987;117:901–15. [PubMed] Hanny PE, Hauselmann HJ.
147.) Cerebral vasculitis as the only manifestation of Borrelia burgdorferi
infection in a 17-year-old patient with basal ganglia infarction. Eur
Neurol. 2003;50:109–12. [PubMed] Heinrich A, Khaw AV, Ahrens N, Kirsch M,
Dressel A.
148.)[Vasculitis course of neuroborreliosis with thalamic infarct]. [in
German]. Nervenarzt. 1997;68:339–41. [PubMed] Keil R, Baron R, Kaiser R,
Deuschl G.
149.) Large cerebral vessel occlusive disease in Lyme neuroborreliosis.
Neuropediatrics. 2002;33:37–40. [PubMed] Klingebiel R, Benndorf G, Schmitt
M, von Moers A, Lehmann R.
150.) Systemic, secondary and infectious causes for cerebral vasculitis:
clinical experience with 16 new European cases. Rheumatology International.
2009;30(11):1471-1476. doi:10.1007/s00296-009-1172-4. [PubMed] Kraemer M,
Berlit P.
151.) Borrelia rhombencephalomyelopathy. Arch Neurol. 1991;48:832–6. [PubMed]
Kuntzer T, Bogousslavsky J, Miklossy J, Steck AJ, Janzer R, Regli F.
152.) Stroke-like Phenomena Revealing Multifocal Cerebral Vasculitis in
Pediatric Lyme Neuroborreliosis. J Child Neurol. 2015 Aug;30(9):1226-9. doi:
10.1177/0883073814552104. [PubMed] Kurian M, Pereira VM, Vargas MI, Fluss
J.
153.)[Ischemic stroke caused by neuroborreliosis]. [in French]. Arch Pediatr.
1999;6(12):1302-5. [PubMed] Laroche C, Lienhardt A, Boulesteix J.
154.) Stroke Due to Lyme Neuroborreliosis: Changes in Vessel Wall Contrast
Enhancement. J Neuroimag. 2012;22(12):210–2. [PubMed] Lebas A, Toulgoat F,
Saliou G, Husson B, Tardieu M.
155.) Stroke in neuroborreliosis. Stroke. 1990;21:1232–5. [PubMed] May EF,
Jabbari B.
156.) Unusual manifestations of nervous system Borrelia burgdorferi
infection. Arch Neurol. 1987;44:781–3. [PubMed] Midgard R, Hofstad H.
157.) Meningovascular form of neuroborreliosis: similarities between
neuropathological findings in a case of Lyme disease and those occurring in
tertiary neurosyphilis. Acta Neuropathol. 1990;80:568–72. [PubMed] Miklossy
J, Kuntzer T, Bogousslavsky J, Regli F, Janzer RC.
158.) Biology and neuropathology of dementia in syphilis and Lyme disease.
Handb Clin Neurol. 2008;89:825–44. [PubMed] Miklossy J.
159.) Neuroborreliosis simulating a progressive stroke. Acta Neurol Scand.
1990;81:471–4. [PubMed] Olsson JE, Zbornikova V.
160.) Stroke due to Lyme disease. Neurology. 1993;43:2705–7. [PubMed] Reik
L., Jr
161.) [Multiple ischemic strokes due to Borrelia garinii meningovasculitis].
[in French]. Rev Neurol (Paris) 2010;166:931–4. [PubMed] Rey V, Du Pasquier
R, Muehl A, Peter O, Michel P.
162.) Neuroborreliosis with vasculitis causing stroke-like manifestations.
Eur Neurol. 2004;51:49–50. [PubMed] Romi F, Krakenes J, Aarli JA, Tysnes
OB.
163.) Cerebral vasculitis with multiple infarcts caused by lyme disease.
Cerebrovasc Dis. 2004;17:79–81. [PubMed] Schmiedel J, Gahn G, von Kummer R,
Reichmann H.
164.) [Neuroborreliosis with extensive cerebral vasculitis and multiple
cerebral infarcts]. [in German]. Nervenarzt. 1999;70:167–71. [PubMed]
Schmitt AB, Kuker W, Nacimiento W.
165.) The long-term clinical outcomes of Lyme disease. A population-based
retrospective cohort study. Ann Intern Med. 1994;121:560–7. [PubMed]
Shadick NA, Phillips CB, Logigian EL, et al.
166.) Recurrent ischemic strokes revealing Lyme meningovascularitis. Rev
Neurol (Paris) 2009;165:273–7. [PubMed] Sparsa L, Blanc F, Lauer V, Cretin
B, Marescaux C, Wolff V.
167.) Unexplained cerebral vasculitis and stroke: keep Lyme neuroborreliosis
in mind. Lancet Neurol. 2007;6:756–7. [PubMed] Topakian R, Stieglbauer K,
Aichner FT.
168.) Cerebral angiopathy and recurrent strokes following Borrelia
burgdorferi infection. J Neurol Neurosurg Psychiat. 1987;50:1703–4. [PubMed
Central] Uldry PA, Regli F, Bogousslavsky J.
169.) Acute ischaemic pontine stroke revealing lyme neuroborreliosis in a
young adult. Acta Neurol Belg. 2008;108:103–6. [PubMed] Van Snick S, Duprez
TP, Kabamba B, Van De Wyngaert FA, Sindic CJ.
170.) Basal meningovasculitis and occlusion of the basilar artery in two
cases of Borrelia burgdorferi infection. Neurology. 1988;38:1317–9. [PubMed]
Veenendaal-Hilbers JA, Perquin WV, Hoogland PH, Doornbos L.
171.) Cerebrovascular Events in Lyme Neuroborreliosis. J Stroke Cerebrovasc
Dis. 2015 Jul;24(7):1671-8. doi:10.1016/j.jstrokecerebrovasdis.2015.03.056.
[PubMed] Wittwer B, Pelletier S, Ducrocq X, Maillard L, Mione G, Richard S.
172.) Vasculitis and stroke due to Lyme neuroborreliosis – a review.
Infectious Diseases. 2014;47(1):1-6. doi:10.3109/00365548.2014.961544. [PubMed]
Zajkowska J, Garkowski A, Moniuszko A et al.
173.) Lyme neuroborreliosis mimics stroke: a case report. Arch phys Med
Rehab. 2000;81:519–21. [PubMed] Zhang Y, Lafontant G, Bonner FJ., Jr
174.) Intracranial aneurysms in three patients with disseminated Lyme
borreliosis: cause or chance association? J Neurol Neurosurg Psychiatry.
1998;64:636–642. doi: 10.1136/jnnp.64.5.636. [PMC free article] [PubMed]
175.) Lyme borreliosis and intracranial aneurysm. J Neurol Neurosurg
Psychiatry. 1999;66:806–807. doi: 10.1136/jnnp.66.6.806a. [PMC free article]
[PubMed] Polet JD, Weinstein HC.
176.) Lyme-associated parkinsonism: a neuropathologic case study and review
of the literature. Arch Pathol Lab Med. 2003;127(9):1204-6. [PubMed]
Cassarino DS, Quezado MM, Ghatak NR, Duray PH.
177.) Genetics Underlying Atypical Parkinsonism and Related
Neurodegenerative Disorders. Jellinger KA, ed. International Journal of
Molecular Sciences. 2015;16(10):24629-24655. doi:10.3390/ijms161024629 [PubMed]
Scholz SW, Bras J.
178.) Neuroborreliosis Presenting as Acute Disseminated Encephalomyelitis.
Pediatric Emergency Care. 2012;28(12):1374-1376.
doi:10.1097/pec.0b013e318276c51d. [PubMed] Rocha R, Lisboa L, Neves J,
García López M, Santos E, Ribeiro A.
179.) A case of chronic progressive lyme encephalitis as a manifestation of
late lyme neuroborreliosis. Infect Dis Rep. 2014 Dec 11;6(4):5496. doi:
10.4081/idr.2014.5496. eCollection 2014 [PubMed] Verma V, Roman MShah D,
Zaretskaya M, Yassin MH.
180.) Chronic or late lyme neuroborreliosis: analysis of evidence compared
to chronic or late neurosyphilis.
Open Neurol J. 2012;6:146-57. doi: 10.2174/1874205X01206010146. Epub 2012
Dec 28. [PubMed] Miklossy J.
181.) Historic evidence to support a causal relationship between spirochetal
infections and Alzheimer’s disease. Front Aging Neurosci 7, 46. [PMC free
article] [PubMed] Miklossy J (2015)
182.) [Outline of Lyme borreliosis in Brazil]. [in Portuguese]. Rev Hosp
Clin Fac Med Sao Paulo. 1997;52(2):111-7. [PubMed] Yoshinari NH, de Barros
PJ, Bonoldi VL, Ishikawa M, Battesti DM, Pirana S, da Fonseca AH, Schumaker
TT.
=====================================================================
11.) LYME
DISEASE, NEUROBORRELIOSIS, -
LATE LYME MENINGOENCEPHALITIS OR MENINGOMYELOENCEPHALITIS.
=====================================================================
183.) [Progressive Borrelia encephalomyelitis. Chronic manifestation of
erythema chronicum migrans disease of the nervous system]. [in German]. DMW
- Deutsche Medizinische Wochenschrift. 1985;110(26):1039-1042.
doi:10.1055/s-2008-1068956. [PubMed] Ackermann R, Gollmer E, Rehse-Küpper B.
184.) Destructive chronic borrelia meningoencephalitis in a child untreated
for 15 years. Scand J Infect Dis. 1987;19:697–700. [PubMed] Bensch J, Olcen
P, Hagberg L.
185.) Central nervous system infection caused by Borrelia burgdorferi.
Clinico-pathological correlation of three post-mortem cases. Folia
neuropathologica. 1999;37:43–51. [PubMed] Bertrand E, Szpak GM, Pilkowska E,
et al.
186.) [Tick-borne borreliosis. A case of chronic meningoencephalitis caused
by Borrelia burgdorferi]. [in Norwegian]. Tidsskr Nor Laegeforen.
1987;107(1):25-7, 49. [PubMed] Bogsrud T, Odegaard B.
187.) Lyme-associated parkinsonism: a neuropathologic case study and review
of the literature. Arch Pathol Lab Med. 2003;127:1204–6. [PubMed] Cassarino
DS, Quezado MM, Ghatak NR, Duray PH.
188.) [Severe meningoencephalitis in Borrelia burgdorferi infection]. [in
Polish]. Neurol Neurochir Pol. 1998;32:387–93. [PubMed] Czyrny M, Jura E,
Seniow J, Baranska M, Wilske B, Czlonkowska A.
189.) Motor neuron disease features in a patient with neuroborreliosis and a
cervical anterior horn lesion. Acta clinica Belgica. 2009;64:225–7. [PubMed]
De Cauwer H, Declerck S, De Smet J, et al.
190.) Lyme meningoencephalitis: report of a severe, penicillin-resistant
case. Arthritis Rheum. 1987;30:705–8. [PubMed] Diringer MN, Halperin JJ,
Dattwyler RJ.
191.) [Acute severe leukoencephalitis with posterior lesions due to Borrelia
burgdorferi infection]. [in French]. Presse Med. 2003;32:1607–9. [PubMed]
Drouet A, Meyer X, Guilloton L, et al.
192.) Clinical pathologic correlations of Lyme disease by stage. Ann N Y
Acad Sci. 1988;539:65–79. [PubMed] Duray PH, Steere AC.
193.)The spectrum of organ and systems pathology in human Lyme disease.
Zentralbl Bakteriol Mikrobiol Hyg A. 1986;263:169–78. [PubMed] Duray PH,
Steere AC.
194.) Histopathology of clinical phases of human Lyme disease. Rheum Dis
Clin North Am. 1989;15:691–710. [PubMed] Duray PH.
195.) The surgical pathology of human Lyme disease. An enlarging picture. Am
J Surg Pathol. 1987;11(Suppl 1):47–60. [PubMed] Duray PH.
196.) [Isolated meningoencephalitis in Lyme disease]. [in French]. Ann Med
Interne (Paris). 1987;138(2):149-50. [PubMed] Fénelon G, Chaine P, Lèche J,
Guillard A.
197.) [Meningoradiculoencephalitis in Lyme disease. A case with major
regressive mental disorders], [in French]. Presse Med. 1988;17(14):697. [PubMed]
Ferroir J, Reignier A, Nicolle M, Guillard A.
198.) CNS Lyme disease manifestation in children. Przeglad lekarski.
2007;64(Suppl 3):38–40. [PubMed] Kacinski M, Zajac A, Skowronek-Bala B,
Kroczka S, Gergont A, Kubik A.
199.) Case of Borrelia brainstem encephalitis presenting with severe
dysphagia. Clin Neurol. 2010;50:265–7. [PubMed] Kawano Y, Shigeto H,
Shiraishi Y, Ohyagi Y, Kira J.
200.) The clinical spectrum of early Lyme borreliosis in patients with
culture-confirmed erythema migrans. Am J Med. 1996;100:502–8. [PubMed]
Nadelman RB, Nowakowski J, Forseter G, et al.
201.) [Borrelia encephalitis and catatonia in adolescence]. [in German].
Nervenarzt. 1989;60:115–9. [PubMed] Neumarker KJ, Dudeck U, Plaza P.
202.) Inflammatory brain changes in Lyme borreliosis. A report on three
patients and review of literature. Brain. 1996;119( Pt 6):2143–54. [PubMed]
Oksi J, Kalimo H, Marttila RJ, et al.
203.) Fatal encephalitis caused by concomitant infection with tick-borne
encephalitis virus and Borrelia burgdorferi. Clinical infectious diseases:
an official publication of the Infectious. Dis Soc Am. 1993;16:392–6. [PubMed]
Oksi J, Viljanen MK, Kalimo H, et al.
204.) [Recurrent and relapsing course of borreliosis of the nervous system].
[in German]. Wien Klin Wochenschr. 1990;102:4–12. [PubMed] Omasits M,
Seiser A, Brainin M.
205.) Stages and syndromes of neuroborreliosis. J Neurol. 1998;245:262–72. [PubMed]
Oschmann P, Dorndorf W, Hornig C, Schafer C, Wellensiek HJ, Pflughaupt KW.
206.) Central nervous system manifestations of Lyme disease. Arch Neurol.
1989;46:790–5. [PubMed] Pachner AR, Duray P, Steere AC.
207.) [Chronic neuroborreliosis with gait ataxia and cognitive disorders].
[in German]. Praxis (Bern 1994). 1997;86(20):867-9. [PubMed] Pennekamp A,
Jaques M.
208.) Tick-borne encephalitis with polyradiculitis documented by MRI.
Neurology. 2007;68:1232–3. [PubMed] Pfefferkorn T, Feddersen B, Schulte-Altedorneburg
G, Linn J, Pfister HW.
209.) [Meningoencephalomyelitis caused by Borrelia burgdorferi: a case
without epidemiologic history or chronic migratory erythema]. [in Spanish].
Med Clin (Barc). 1989;93:218–20. [PubMed] Ponz E, Graus F, Alvarez R,
Sarmiento X, Vidal J, Grau JM.
210.) Neurologic abnormalities in Lyme disease without erythema chronicum
migrans. Am J Med. 1986;81:73–8. [PubMed] Reik L Jr, Burgdorfer W, Donaldson
JO.
211.) The long-term clinical outcomes of Lyme disease. A population-based
retrospective cohort study. Ann Intern Med. 1994;121:560–7. [PubMed] Shadick
NA, Phillips CB, Logigian EL, et al.
212.) Chronic progressive neurological involvement in Borrelia burgdorferi
infection. J Neurol. 1987;234:40–3. [PubMed] Weder B, Wiedersheim P, Matter
L, Steck A, Otto F.
===================================================================
12.) LYME
DISEASE- LATE STAGE: ATROPHIC FORM OF LYME
MENINGOENCEPHALITIS WITH DEMENTIA & SUBACUTE PRESENILE DEMENTIA &
NEUROPSYCHIATRIC MANIFESTATIONS
===================================================================
213.) Cerebral atrophy in Lyme disease. Neuroradiology. 1990;32:252. [PubMed]
Aasly J, Nilsen G.
214.) Alzheimers disease: A novel hypothesis integrating spirochetes,
biofilm, and the immune system. Journal of Neuroinfectious Diseases.
2016;07(01). doi:10.4172/2314-7326.1000200.[https://www.researchgate.net/publication/294089000_Alzheimer's_
Disease_A_Novel_Hypothesis_Integrating_Spirochetes_Biofilm_and_the_Immune_System]Allen
HB, Morales D.
215.) Dementia associated with infectious diseases. International
Psychogeriatrics. 2005;17(S1):S65. doi:10.1017/s104161020500195x. [PubMed]
Almeida OP, Lautenschlager NT.
216.) A study on the association between infectious burden and Alzheimer's
disease. European Journal of Neurology. 2014;22(12):1519-1525.
doi:10.1111/ene.12477. [PubMed] Bu X, Yao X, Jiao S et al.
217.) Multiple neurologic manifestations of Borrelia burgdorferi infection.
Rev Neurol. 1988;144:765–75. [PubMed] Dupuis MJ.
218.) The surgical pathology of human Lyme disease. An enlarging picture. Am
J Surg Pathol. 1987;11(Suppl 1):47–60. [PubMed] Duray PH.
219.) Microbes and Alzheimer’s Disease. Journal of Alzheimer's Disease.
2016;51(4):979-984. doi:10.3233/jad-160152. [PubMed] Itzhaki R, Lathe R,
Balin B et al.
220.) [Mental disorders in the course of lyme borreliosis and tick borne
encephalitis] [in Polish]. Przeglad epidemiologiczny. 2002;56:37–50. [PubMed]
Juchnowicz D, Rudnik I, Czernikiewicz A, Zajkowska J, Pancewicz SA.
221.) Lyme disease presenting as subacute transverse myelitis. Acta Neurol
Belg. 2009;109(4):326-9. [PubMed] Koc F, Bozdemir H, Pekoz T, Aksu H, Ozcan
S, Kurdak H.
222.) Concurrent neocortical borreliosis and Alzheimer's disease. Human
Pathology. 1987;18(7):759-761. doi:10.1016/s0046-8177(87)80252-6. [PubMed]
MacDonald A, Miranda J.
223.) Borrelia in the brains of patients dying with dementia. JAMA.
1986;256:2195–6. [PubMed] MacDonald AB.
224.) Can infections cause Alzheimer’s disease? Epidemiologic Reviews.
2013;35(1):161–180. doi:10.1093/epirev/mxs007. [PubMed] Mawanda F, Wallace
R.
225.) Senile plaques, neurofibrillary tangles and neuropil threads contain
DNA? Journal of Spirochetal and Tick Borne-Diseases. 1995;2:1–5. Miklossy
J, Gern L, Darekar P, Janzer RC, Van der Loos H.
226.) Further ultrastructural evidence that spirochaetes may play a role in
the aetiology of Alzheimer's disease. Neuroreport. 1994;5:1201–4. [PubMed]
Miklossy J, Kasas S, Janzer RC, Ardizzoni F, Van der Loos H.
227.) Persisting atypical and cystic forms of Borrelia burgdorferi and local
inflammation in Lyme neuroborreliosis. Journal of Neuroinflammation.
2008;5(1):40. doi:10.1186/1742-2094-5-40. [PubMed] Miklossy J, Kasas S, Zurn
A, McCall S, Yu S, McGeer P.
228.) Borrelia burgdorferi persists in the brain in chronic Lyme
neuroborreliosis and may be associated with Alzheimer disease. Journal of
Alzheimer’s Disease. 2004;6(6):639–649. [PubMed] Miklossy J, Khalili K, Gern
L, et al.
229.) Beta-amyloid deposition and Alzheimer’s type changes induced by
Borrelia spirochetes. Neurobiology of Aging. 2006;27(2):228–236.
doi:10.1016/j.neurobiolaging.2005.01.018. [PubMed] Miklossy J, Kis A,
Radenovic A, et al.
230.) Alzheimer’s disease - a neurospirochetosis. Analysis of the evidence
following Koch’s and hill’s criteria. Journal of Neuroinflammation.
2011;8(1):90. doi:10.1186/1742-2094-8-90. [PMC free article] [PubMed]
Miklossy J.
231.) Alzheimer's disease--a spirochetosis? Neuroreport. 1993;4:841–8. [PubMed]
Miklossy J.
231.) Bacterial Amyloid and DNA are Important Constituents of Senile
Plaques: Further Evidence of the Spirochetal and Biofilm Nature of Senile
Plaques. Journal of Alzheimer's Disease. 2016;53(4):1459-1473.
doi:10.3233/jad-160451. [PubMed] Miklossy J.
232.) Chronic inflammation and amyloidogenesis in Alzheimer’s disease --
role of Spirochetes. Journal of Alzheimer’s disease : JAD.
2008;13(4):381–91. [PubMed] Miklossy J.
233.) Emerging roles of pathogens in Alzheimer disease. Expert Reviews in
Molecular Medicine. 2011;13. doi:10.1017/s1462399411002006. [PubMed]
Miklossy J.
234.) Historic evidence to support a causal relationship between spirochetal
infections and Alzheimer’s disease. Frontiers in Aging Neuroscience. 2015;7.
doi:10.3389/fnagi.2015.00046. [PubMed Central] Miklossy J.
235.) The spirochetal etiology of Alzheimer’s disease: A putative
therapeutic approach. In Alzheimer Disease: Therapeutic Strategies.
Proceedings of the Third International Springfield Alzheimer Symposium.
Edited by: Giacobini E, Becker R. Birkhauser Boston Inc.; 1994:, Part I:
41-48. ) Miklossy J.
236.) [Chronic neuroborreliosis with gait ataxia and cognitive disorders]
[in German]. Praxis. 1997;86(20):867–9. https://www.ncbi.nlm.nih.gov/pubmed/9312817.
Accessed February 27, 2017. [PubMed] Pennekamp A, Jaques M.
236.) Neurologic abnormalities in Lyme disease without erythema chronicum
migrans. Am J Med. 1986;81:73–8. [PubMed] Reik L Jr, Burgdorfer W,
Donaldson JO.
237.) Dementia in Lyme disease. Presse Med. 1994;23:861. [PubMed] Schaeffer
S, Le Doze F, De la Sayette V, Bertran F, Viader F.
238.) [Neuroborreliosis: CT and MRI findings in 14 cases. Preliminary
communication] [in Polish]. Neurologia i neurochirurgia polska.
2002;35(5):803–13. [PubMed] Tarasów E, Ustymowicz A, Zajkowska J,
Hermanowska-Szpakowicz T.
239.) Rapidly progressive frontal-type dementia associated with Lyme
disease. J Neuropsychiatry Clin Neurosci. 1995;7:345–7. [PubMed] Waniek C,
Prohovnik I, Kaufman MA, Dwork AJ.
240.)The underdiagnosis of neuropsychiatric lyme disease in children and
adults. Psychiatric Clinics of North America. 1998;21(3):693-703.
doi:10.1016/s0193-953x(05)70032-0. [PubMed] Fallon B, Kochevar J, Gaito A,
Nields J.
241.) Lyme disease: a neuropsychiatric illness. The Am J Psychiatr.
1994;151:1571–83. [PubMed] Fallon BA, Nields JA.
242.) Psychiatric manifestations of Lyme borreliosis. J Clin Psychiatry.
1993;54(7):263-8. [Europe PMC] [PubMed] Fallon B, Nields J, Parsons B,
Liebowitz M, Klein D.
243.) A controlled study of cognitive deficits in children with chronic Lyme
disease. J Neuropsychiatry Clin Neurosci. 2001;13(4):500-7. [PubMed] Tager
FA, Fallon BA, Keilp J, Rissenberg M, Jones CR, Liebowitz MR.
===================================================================
13.) LYME
DISEASE- LATE STAGE:
BONE, JOINT
AND MUSCULOSKELETAL MANIFESTATIONS
===================================================================
244.) Distinguishing Lyme from septic knee monoarthritis in Lyme
disease-endemic areas. Pediatrics. 2013;131(3):e695-701.
doi:10.1542/peds.2012-2531. [PubMed] Deanehan JK, Kimia AA, Tan Tanny SP,
et al.
245.) Analysis of Borrelia burgdorferi genotypes in patients with Lyme
arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains
in antibiotic-refractory arthritis. Arthritis Rheum. 2009;60(7):2174-2182.
doi:10.1002/art.24812. [PubMed] Jones KL, McHugh GA, Glickstein LJ, Steere
AC.
246.) Temporomandibular joint involvement caused by Borrelia Burgdorferi. J
Cranio-Maxillo-fac Surg Off Publ Eur Assoc Cranio-Maxillo-fac Surg.
2007;35(8):397-400. doi:10.1016/j.jcms.2007.06.003. [PubMed] Lesnicar G,
Zerdoner D.
247.) The incidence of Borrelia burgdorferi, Anaplasma phagocytophilum and
Babesia microti coinfections among foresters and farmers in eastern Poland.
J Vector Borne Dis. 2016;53(4):348-354. [PubMed] Pañczuk A, Tokarska-Rodak
M, Koziol-Montewka M, Plewik D.
248.) Good outcomes of Lyme arthritis in 24 patients in an endemic area of
Switzerland. Jt Bone Spine Rev Rhum. 2004;71(1):39-43.
doi:10.1016/S1297-319X(03)00160-X. [PubMed] Renaud I, Cachin C, Gerster
J-C.
249.) Epidemiology and Clinical Similarities of Human Spirochetal Diseases.
Clinical Infectious Diseases. 1989;11(Supplement 6):S1460-S1469. doi:
10.1093/clinids/11.supplement_6.s1460. [PubMed] Schmid G.
250.) [Outline of Lyme borreliosis in Brazil]. [in Portuguese]. Rev Hosp
Clin Fac Med Sao Paulo. 1997;52(2):111-7. [PubMed]Yoshinari NH, de Barros PJ,
Bonoldi VL, Ishikawa M, Battesti DM, Pirana S, da Fonseca AH, Schumaker TT.
251.) Disease expression of Lyme borreliosis in northeastern France. Eur J
Clin Microbiol Infect Dis. 2001;20(4):225-30. [PubMed] Lipsker D, Hansmann
Y, Limbach F, Clerc C, Tranchant C, Grunenberger F, Caro-Sampara F, Attali
P, Frey M, Kubina M, Piémont Y, Sibilia J, Jaulhac B;
252.) Parsonage-Turner syndrome revealing Lyme borreliosis. Jt Bone Spine
Rev Rhum. 2009;76(2):202-204. doi:10.1016/j.jbspin.2008.07.013. [PubMed]
=======================================================================
14.) LYME
DISEASE, LATE STAGE:
OCULOPATHY,
LIVER, KIDNEY AND RESPIRATORY MANIFESTATIONS
======================================================================
253.) Acute isolated partial oculomotor nerve palsy due to Lyme
neuroborreliosis in a 5 year old girl. European Journal of Paediatric
Neurology. 2016;20(6):977-979. doi:10.1016/j.ejpn.2016.05.022. [PubMed]
Drenckhahn A, Spors B, Knierim E.
254.) Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am
J Ophthalmol. 1995;119(2):127-135. [PubMed] Karma A, Seppälä I, Mikkilä H,
Kaakkola S, Viljanen M, Tarkkanen A.
255.) [Ocular manifestations of Lyme borreliosis in northwest Croatia]. [in
Croatian]. Lijec Vjesn. 2004;126(5-6):124-128. [PubMed] Golubic D, Vinkovic
T, Turk D, Hranilovic J, Slugan I.
256.)The expanding clinical spectrum of ocular lyme borreliosis.
Ophthalmology. 2000;107(3):581-587. [PubMed] Mikkilä HO, Seppälä IJ,
Viljanen MK, Peltomaa MP, Karma A.
257.) Concurrent Lyme disease and babesiosis. Evidence for increased
severity and duration of illness. JAMA. 1996;275(21):1657-1660. [PubMed]
Krause PJ, Telford SR, Spielman A, et al.
258.) [Lyme disease with hepatitis and corticosteroids: a case report]. [in
French]. Rev Med Interne. 2012;33(6):339-342.
doi:10.1016/j.revmed.2012.01.016. [PubMed] Muslmani M, Gilson M, Sudre A,
Juvin R, Gaudin P.
259.) Lyme disease-associated glomerulonephritis. Nephrol Dial Transplant
2011; 26 (9): 3054-3056. doi: 10.1093/ndt/gfr335 [PubMed]Finnian R. Mc
Causland, Sophie Niedermaier, Vanesa Bijol, Helmut G. Rennke, Mary E. Choi,
John P. Forman;
260.) Chronic Lyme borreliosis associated with minimal change glomerular
disease: a case report. BMC Nephrol. 2017;18(1).
doi:10.1186/s12882-017-0462-4. [PubMed] Florens N, Lemoine S,
Guebre-Egziabher F, et al.
262.) Lyme disease and glomerulonephritis, Ir Med J, 1999, vol. 92 pg. 372 [PubMed]
Kelly B, Finnegan P, Cormican M, et al.
263.) Membranous glomerulonephritis secondary to Borrelia burgdorferi
infection presenting as nephrotic syndrome, NDT Plus, 2010, vol. 3 (pg.
105-106)[PubMed] Papineni P, Doherty T, Pickett T, et al.
264.) MPGN and nephrotic syndrome secondary to Lyme disease, Am J Kidney Dis
(abstract), 2008, vol. 51 pg. B83 Rawal B, Rovner L, Thakar C, et al.
CrossRef
265.) Diaphgramatic paralysis due to Lyme disease. Eur Respir J.
1999;13:700–702. doi: 10.1183/09031936.99.13370099. [PubMed] [Cross Ref]
Faul JL, Ruoss S, Doye RL.
266.) Acute lyme infection presenting with amyopathic dermatomyositis and
rapidly fatal interstitial pulmonary fibrosis: a case report. J Med Case
Reports. 2010;4(1). doi:10.1186/1752-1947-4-187. [PubMed] Nguyen H, Le C,
Nguyen H.
267.) Neuroborreliosis as a cause of respiratory failure. J Neurol.
1992;242:604–607. doi: 10.1007/BF00868815. [PubMed] [Cross Ref] Silva MT,
Sophar M, Howard RS.
=========================================================
15.) LYME
DISEASE, LATENT STAGE,
UNESPICIFIED
=========================================================
268.) Spirochetal infection of the central nervous system. Infect Dis Clin
North Am. 1990 Dec;4(4):731-46. PMID: 2277196 [PubMed] Coyle PK1, Dattwyler
R.
269.) Activation of latent Lyme borreliosis concurrent with a herpes simplex
virus type 1 infection. Scand J Infect Dis. 2002;34(12):922-4. PMID:12587627
[PubMed] Gylfe A, Wahlgren M, Fahlén L, Bergström S.
270.)[The classification of Lyme borreliosis (Lyme disease)]. Ter Arkh.
1995;67(11):49-51. PMID: 8571252 [PubMed] Lesniak OM, Belikov ES.
271.) Persisting atypical and cystic forms of Borrelia burgdorferi and local
inflammation in Lyme neuroborreliosis. J Neuroinflammation. 2008;5(1):40.
doi:10.1186/1742-2094-5-40. [PubMed] Miklossy J, Kasas S, Zurn AD, McCall
S, Yu S, McGeer PL.
273.)[Clinical manifestations of neuroborreliosis in the Volga region]. Ter
Arkh. 2010;82(11):68-70. [Article in Russian] [PubMed] Nafeev AA, Klimova
LV.
274.) Spirochetal diseases of the CNS. Neurol Clin. 1986;4(1):207-222. [PubMed]
Pachner AR.
275.) Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the
cerebrospinal fluid without concurrent inflammatory signs. Neurology. 1989
Aug;39(8):1118-20. PMID: 2668788 [PubMed] Pfister HW, Preac-Mursic V,
Wilske B, Einhäupl KM, Weinberger K.
276.) Epidemiology and clinical similarities of human spirochetal diseases.
Rev Infect Dis. 1989;11 Suppl 6:S1460-9. [PubMed] Schmid GP.
277.) [Outline of Lyme borreliosis in Brazil]. Rev Hosp Clin Fac Med Sao
Paulo. 1997;52(2):111-7. [Article in Portuguese] [PubMed]Yoshinari NH, de
Barros PJ, Bonoldi VL, Ishikawa M, Battesti DM, Pirana S, da Fonseca AH,
Schumaker TT.
278.) Avitabile C, Harris M, Chowdhury D. Cardiac Magnetic Resonance
Characterizes Myocarditis in a 16-Year-Old Female With Lyme Disease. World
Journal for Pediatric and Congenital Heart Surgery. 2016;7(3):394-396.
doi:10.1177/2150135115593134. [PubMed] Avitabile C, Harris M, Chowdhury D.
279.) [Lyme carditis]. [Article in Polish]. Pol Med J.
2015;39(230):111–115. [PubMed] Blaut-Jurkowska J, Olszowska M, Kaznica-Wiatr
M, Piotr Podolec P.
280.) Recent-onset dilated cardiomyopathy associated with Borrelia
burgdorferi infection. Herz. 2015;40(6):892-897.
doi:10.1007/s00059-015-4308-1. [PubMed] Kuchynka P, Palecek T, Havranek S et
al.
281.) [Inflammatory borrelia - associated dilated cardiomyopathy]. [Article
in Czech]. Vnitr Lek. 2013;59(12):1107-10. [PubMed] .) Plocarová K.
===================================================================
===================================================================
DATA-MEDICOS/DERMAGIC-EXPRESS No 19-(207) 16/12/2.017 DR. JOSE LAPENTA R.
===================================================================
Produced
by Dr. Jose Lapenta R. Dermatologist 2.017
Maracay Estado Aragua Venezuela 2.017
Telf: 0416-6401045- 02432327287-02432328571
loading...
|